CIK 0001533040 · Non-accelerated filer<br>Smaller reporting company
Phio Pharmaceuticals Corp.
Sign in to watch- Ticker
- PHIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 453215903
- Phone
- (508) 767-3861
- Business address
- 411 SWEDELAND ROAD, SUITE 23-1080, KING OF PRUSSIA, PA, 19406
- Former names
- RXi Pharmaceuticals Corp
- CT ORDER Other Confidential Order
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 8-K Event Results of operations
- 10-K Report Annual Report
- 4 Insider Changes in Ownership
- 4/A Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- SC 13G/A Stake Amended Statement of Ownership
- CERTNAS Other Certification by the Nasdaq Stock Market
- 8-A12B Other Registration of Securities
- 8-K Event Unregistered share sale · Bylaws or fiscal year change · Other events
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement · New debt or obligation
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
Page 38 of 45 · 897 filings